After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Cassava Sciences Inc is $116.43M. A total of 1.41 million shares were traded on the day, compared to an average of 5.64M shares.
In the most recent transaction, Kupiec James William sold 4,000 shares of SAVA for 3.87 per share on Nov 29 ’24. After the transaction, the Chief Medical Officer now owns 0 company shares. In a previous transaction on Nov 29 ’24, Schoen Eric sold 59,800 shares at 3.86 per share. SAVA shares that Chief Financial Officer owns now total 11,500.
Among the insiders who sold shares, Schoen Eric disposed of 2,000 shares on Nov 29 ’24 at a per-share price of $3.82. This resulted in the Chief Financial Officer holding 0 shares of SAVA after the transaction. In another insider transaction, Schoen, Eric J. (SAVA) bought 2,000 shares at $3.82 per share on Nov 29 ’24.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, SAVA has a high of $42.20 and a low of $2.23.
As of this writing, SAVA has an earnings estimate of -$0.68 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$0.68 per share and a lower estimate of -$0.68.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. SAVA’s latest balance sheet shows that the firm has $233.44M in Cash & Short Term Investments as of fiscal 2021. There were $236.00k in debt and $12.53M in liabilities at the time. Its Book Value Per Share was $3.47, while its Total Shareholder’s Equity was $253.91M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SAVA is Buy with a score of 4.00.
